US Physical Therapy (USPh), an operator of outpatient physical therapy clinics, has announced the acquisition of a 50% equity stake in a physical therapy and hand therapy practice.
USPh has not disclosed the name of the acquired practice.
Go deeper with GlobalData
The $16.4m deal sees USPh expand its reach with the addition of nine clinic locations. The current practice owners retain the remaining 50% interest.
According to USPh, the newly acquired practice includes significant operations, generating around $11.4m in annual revenues and around 65,000 patient visits every year.
USPh CEO Chris Reading said: “This will be a great partnership in addition to an already strong market for us.”
This move aligns with the company’s strategic growth, as it already operates 678 outpatient physical therapy clinics across 42 states in the US.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataUSPh’s clinics specialise in a range of services, including various orthopaedic-related services, sports injury treatment, neurological injury rehabilitation, and worker injury rehabilitation.
Beyond clinic ownership and operation, USPh manages 41 physical therapy facilities for third-party entities, which comprise hospitals and physician groups.
The industrial injury prevention arm of the company is another facet of its diversified services.
It provides on-site support for client employees, encompassing injury prevention and rehabilitation, functional capacity evaluations, employment testing, performance optimisation, and ergonomic assessments.
Founded in 1990, USPh mainly expands its operations through private practice partnerships along with a combination of strategic acquisitions and de novo development.
